Michael Severino

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
5 years
Director since
2023

5 years of board service in total across 3 boards, counting each seat separately. Longest: Avantor Inc., 3 years.

Avantor Inc. Director
3 years · Since 2023
Viatris Inc. Director
1 year · Since 2025
Sarepta Therapeutics Inc. Director · Chief Executive Officer
3 months · Since 2026

Chief executive roles

Sarepta Therapeutics Inc. · Chief Executive Officer
Since July 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 28, 2026 Sarepta Therapeutics Inc. Grant or award +756,104 — —
May 7, 2026 Avantor Inc. Grant or award +25,270 — —
Mar 6, 2026 Viatris Inc. Option exercise +25,112 — —
Mar 6, 2026 Viatris Inc. Option exercise +919 — —
May 8, 2025 Avantor Inc. Grant or award +17,100 — —
May 9, 2024 Avantor Inc. Grant or award +8,477 — —
May 11, 2023 Avantor Inc. Grant or award +9,808 — —

Questions about Michael Severino

What boards is Michael Severino on?

Michael Severino sits on the boards of Avantor Inc., Sarepta Therapeutics Inc. and Viatris Inc.

What company is Michael Severino the CEO of?

Michael Severino has been Chief Executive Officer of Sarepta Therapeutics Inc. since July 2026.

How long has Michael Severino served on boards?

Our records show at least 5 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.